Literature DB >> 20718835

Prognostic significance of high-grade dysplasia in colorectal adenomas.

A D Toll1, D Fabius, T Hyslop, E Pequignot, A J DiMarino, A Infantolino, J P Palazzo.   

Abstract

AIM: Colonoscopy to detect and remove polyps has contributed to a reduction in colorectal carcinoma. Three-year follow up is recommended for patients considered to be at high risk (at least three adenomas, adenoma ≥ 1 cm, villous or high-grade features). Our study focused on patients diagnosed with high-grade dysplasia with regard to initial management and follow up.
METHOD: A search of patients who had had endoscopic removal of a high-grade adenoma was carried out. Patients with the following were excluded: follow up of < 1 year, polyposis syndromes, prior colon cancer and a diagnosis of adenocarcinoma within 6 months following initial diagnosis.
RESULTS: Eighty-three patients treated between 1999 and 2007 for high-grade dysplasia (HGD) in a colorectal adenoma were identified. Over a median follow-up period of 4 years, 53 (64%) developed further adenomatous polyps. Among these, 7% had an adenoma with HGD or an adenocarcinoma. In all these patients, the initial high-grade adenoma was > 1 cm in diameter. Initial follow-up colonoscopy was performed on average 7 months following the initial diagnosis. Ten per cent of patients underwent prophylactic segmental resection, and 6% received argon laser therapy.
CONCLUSION: The study demonstrates that patients who have a colorectal adenoma > 1 cm with HGD may be at high risk of developing further adenomas with HGD or carcinoma. Close follow up is warranted.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2011        PMID: 20718835     DOI: 10.1111/j.1463-1318.2010.02385.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  11 in total

1.  A novel method for screening colorectal cancer by infrared spectroscopy of peripheral blood mononuclear cells and plasma.

Authors:  Eyal Barlev; Udi Zelig; Omri Bar; Cheli Segev; Shaul Mordechai; Joseph Kapelushnik; Ilana Nathan; Felix Flomen; Hanoch Kashtan; Ram Dickman; Osnat Madhala-Givon; Nir Wasserberg
Journal:  J Gastroenterol       Date:  2015-06-26       Impact factor: 7.527

Review 2.  Multi-Target Stool DNA Test: Is the Future Here?

Authors:  Seth Sweetser; David A Ahlquist
Journal:  Curr Gastroenterol Rep       Date:  2016-06

Review 3.  Evidenced-Based Screening Strategies for a Positive Family History.

Authors:  Jennifer M Kolb; Dennis J Ahnen; N Jewel Samadder
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-04-14

Review 4.  Multi-target stool DNA test: a new high bar for noninvasive screening.

Authors:  David A Ahlquist
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

5.  Biodegradable fluorescent nanoparticles for endoscopic detection of colorectal carcinogenesis.

Authors:  Stephan Rogalla; Krzysztof Flisikowski; Dimitris Gorpas; Aaron T Mayer; Tatiana Flisikowska; Michael J Mandella; Xiaopeng Ma; Kerriann M Casey; Stephen A Felt; Dieter Saur; Vasilis Ntziachristos; Angelika Schnieke; Christopher H Contag; Sanjiv S Gambhir; Stefan Harmsen
Journal:  Adv Funct Mater       Date:  2019-10-10       Impact factor: 18.808

Review 6.  Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.

Authors:  Jennifer M Kolb; Christine L Molmenti; Swati G Patel; David A Lieberman; Dennis J Ahnen
Journal:  Am J Gastroenterol       Date:  2020-07       Impact factor: 12.045

7.  Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer.

Authors:  Mohamad A Mouchli; Lidia Ouk; Marianne R Scheitel; Alisha P Chaudhry; Donna Felmlee-Devine; Diane E Grill; Shahrooz Rashtak; Panwen Wang; Junwen Wang; Rajeev Chaudhry; Thomas C Smyrk; Ann L Oberg; Brooke R Druliner; Lisa A Boardman
Journal:  World J Gastroenterol       Date:  2018-02-28       Impact factor: 5.742

8.  Quantitative risk of positive family history in developing colorectal cancer: A meta-analysis.

Authors:  Parsa Mehraban Far; Abdulaziz Alshahrani; Mohammad Yaghoobi
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

9.  Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer.

Authors:  Cecilia Högberg; Pontus Karling; Jörgen Rutegård; Mikael Lilja; Thomas Ljung
Journal:  Scand J Prim Health Care       Date:  2013-11-06       Impact factor: 2.581

10.  SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.

Authors:  Alexander Semaan; Anne van Ellen; Sebastian Meller; Dominik Bergheim; Vittorio Branchi; Philipp Lingohr; Diane Goltz; Jörg C Kalff; Glen Kristiansen; Hanno Matthaei; Dimitrios Pantelis; Dimo Dietrich
Journal:  Clin Epigenetics       Date:  2016-09-20       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.